Status:
COMPLETED
A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.
Lead Sponsor:
Daiichi Sankyo
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Determine the effect of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on pravastatin therapy for at least 4 weeks.
Eligibility Criteria
Inclusion
- Male or female \> or = to 18 years of age
- On a stable dose of pravastatin
- LDL-C \> or = to 100 mg/dL and \< or = 250 mg/dL
- Triglycerides \< or = to 300 mg/dL
- Women are not pregnant or breast-feeding or planning to become pregnant
- Women have had a hysterectomy or tubal ligation, or who are post-menopausal or who practice an accepted method of birth control as specified in the protocol
Exclusion
- BMI \> 40 kg/m2
- History of allergic or toxic reaction to colesevelam HCL
- History of swallowing disorder
- Any serious condition that would interfere with the conduct of the study
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT00755352
Start Date
November 1 2002
End Date
April 1 2005
Last Update
April 3 2015
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles, California, United States
2
Castle Rock, Colorado, United States
3
Jacksonville, Florida, United States
4
Pembroke Pines, Florida, United States